Nevro Corp (NYSE:NVRO)’s traded shares stood at 1.03 million during the latest session, with the company’s beta value hitting 0.97.The NVRO share’s 52-week high remains $17.75, putting it -210.31% down since that peak but still an impressive 44.76% since price per share fell to its 52-week low of $3.16. The company has a valuation of $214.34M, with an average of 1.62 million shares in intraday trading volume over the past 10 days and average of 774.04K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Nevro Corp (NVRO), translating to a mean rating of 3.27. Of 15 analyst(s) looking at the stock, 2 analyst(s) give NVRO a Sell rating. 0 of those analysts rate the stock as Overweight while 6 advise Hold as 7 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.75.
Nevro Corp (NYSE:NVRO) trade information
The 5-day price performance for the stock is 12.82%, and 59.33% over 30 days. With these gigs, the year-to-date price performance is 53.76%. Short interest in Nevro Corp (NYSE:NVRO) saw shorts transact 2.84 million shares and set a 5.01 days time to cover.
The extremes give us $4 and $6.89 for target low and target high price respectively. As such, NVRO has been trading -20.45% off suggested target high and 30.07% from its likely low.
Nevro Corp (NVRO) estimates and forecasts
Looking at statistics comparing Nevro Corp share performance against respective industry, we note that the company has underperformed competitors. Nevro Corp (NVRO) shares are 18.43% up over the last 6 months, with its year-to-date growth rate lower than industry average at 2.44% against 16.50%. The rating firms project that company’s revenue will shrink -4.56% compared to the previous financial year.
Revenue forecast for the current quarter as set by 13 analysts is 101.93M. Meanwhile, for the current quarter, a total of 10 analyst(s) estimate revenue growth to 94.1M.Earnings reports from the last fiscal year show that sales brought in 116.18M and 101.9M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to fall -12.26% before dropping -7.66% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -9.37% for the past 5-year period. While 2025 is set for a 4.83% return in earnings, projections for the next 5 years are at 5.85% annually.
NVRO Dividends
Nevro Corp has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Nevro Corp (NYSE:NVRO)’s Major holders
Nevro Corp insiders hold 3.87% of total outstanding shares, with institutional holders owning 102.14% of the shares at 106.25% float percentage. In total, 102.14% institutions holds shares in the company, led by ARROWMARK COLORADO HOLDINGS LLC. As of 2024-06-30, the company held over 4.29 million shares (or 11.7615% of shares), all amounting to roughly $36.11 million.
The next major institution holding the largest number of shares is ARMISTICE CAPITAL, LLC with 3.67 million shares, or about 10.0693% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $30.92 million.
We also have Vanguard Explorer Fund, Inc. and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Nevro Corp (NVRO) shares. Going by data provided on Oct 31, 2024 , Vanguard Explorer Fund, Inc. holds roughly 2.12 shares. This is just over 5.65% of the total shares, with a market valuation of $12.14 million. Data from the same date shows that the other fund manager holds a little less at 1.15, or 3.08% of the shares, all valued at about 6.61 million.
